The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 19, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions

Clinical IVb Stage Oral Squamous Cell Carcinomas Patients

Interventions

DRUG

Adebrelimab

Adebrelimab：20mg/kg, ivdrip, D1，Q3W

Trial Locations (1)

RECRUITING

School of Stomatology Wuhan University, Hubei

All Listed Sponsors

lead

Hospital of Stomatology, Wuhan University

OTHER